feed,title,long_url,short_url
Benzinga,Ionis Pharma's Ligand-Conjugated Antisense Hits Primary Endpoint Goal In Hereditary Angioedema Study,https://benzinga.com/general/biotech/21/03/20384318/ionis-pharmas-ligand-conjugated-antisense-hits-primary-endpoint-goal-in-hereditary-angioedema-stu,https://j.mp/3wb4KHu
